SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

Citigroup Maintains Neutral on Ultragenyx Pharmaceutical, Raises Price Target to $66

Citigroup maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Neutral and raises the price target from $53 to $66.

Benzinga · 05/08/2020 12:10

Citigroup maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Neutral and raises the price target from $53 to $66.